Cargando…

Neuroprotective Effects of Transferrin in Experimental Glaucoma Models

Iron is essential for retinal metabolism, but an excess of ferrous iron causes oxidative stress. In glaucomatous eyes, retinal ganglion cell (RGC) death has been associated with dysregulation of iron homeostasis. Transferrin (TF) is an endogenous iron transporter that controls ocular iron levels. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Youale, Jenny, Bigot, Karine, Kodati, Bindu, Jaworski, Thara, Fan, Yan, Nsiah, Nana Yaa, Pappenhagen, Nathaniel, Inman, Denise M., Behar-Cohen, Francine, Bordet, Thierry, Picard, Emilie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659282/ https://www.ncbi.nlm.nih.gov/pubmed/36361544 http://dx.doi.org/10.3390/ijms232112753

Ejemplares similares

Transferrin Non-Viral Gene Therapy for Treatment of Retinal Degeneration
por: Bigot, Karine, et al.
Publicado: (2020)

Iron is neurotoxic in retinal detachment and transferrin confers neuroprotection
por: Daruich, Alejandra, et al.
Publicado: (2019)

From Rust to Quantum Biology: The Role of Iron in Retina Physiopathology
por: Picard, Emilie, et al.
Publicado: (2020)

Comparative Analysis of Urso- and Tauroursodeoxycholic Acid Neuroprotective Effects on Retinal Degeneration Models
por: Daruich, Alejandra, et al.
Publicado: (2022)

Destabilizing COXIV in Müller Glia Increases Retinal Glycolysis and Alters Scotopic Electroretinogram
por: Nsiah, Nana Yaa, et al.
Publicado: (2022)

Oral Ursodeoxycholic Acid Crosses the Blood Retinal Barrier in Patients with Retinal Detachment and Protects Against Retinal Degeneration in an Ex Vivo Model
por: Daruich, Alejandra, et al.
Publicado: (2021)

The protective role of transferrin in Müller glial cells after iron-induced toxicity
por: Picard, Emilie, et al.
Publicado: (2008)

Ocular Hypertension Results in Hypoxia within Glia and Neurons throughout the Visual Projection
por: Jassim, Assraa Hassan, et al.
Publicado: (2022)

Overexpressed or intraperitoneally injected human transferrin prevents photoreceptor degeneration in rd10 mice
por: Picard, Emilie, et al.
Publicado: (2010)

Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease
por: Daruich, Alejandra, et al.
Publicado: (2019)

Long-term HIF-1α stabilization reduces respiration, promotes mitophagy, and results in retinal cell death
por: Nsiah, Nana Yaa, et al.
Publicado: (2023)

Oral administration of a dual ET(A)/ET(B) receptor antagonist promotes neuroprotection in a rodent model of glaucoma
por: Kodati, Bindu, et al.
Publicado: (2022)

Role of Glucocorticoids and Glucocorticoid Receptors in Glaucoma Pathogenesis
por: Patel, Pinkal D., et al.
Publicado: (2023)

Stretch stress propels glutamine dependency and glycolysis in optic nerve head astrocytes
por: Pappenhagen, Nathaniel, et al.
Publicado: (2022)

Early-Onset Glaucoma in egl1 Mice Homozygous for Pitx2 Mutation
por: Kodati, Bindu, et al.
Publicado: (2022)

Reduced AMPK activation and increased HCAR activation drive anti-inflammatory response and neuroprotection in glaucoma
por: Harun-Or-Rashid, Mohammad, et al.
Publicado: (2018)

Neuroprotection in glaucoma
por: Vasudevan, Sushil K, et al.
Publicado: (2011)

Neuroprotection in Glaucoma
por: Nilforushan, Naveed
Publicado: (2012)

Neuroprotection in Glaucoma
por: Doozandeh, Azadeh, et al.
Publicado: (2016)

Neuroprotection in glaucoma
por: Vishwaraj, C R, et al.
Publicado: (2022)

Astragaloside IV Attenuates Ocular Hypertension in a Mouse Model of TGFβ2 Induced Primary Open Angle Glaucoma
por: Kasetti, Ramesh B., et al.
Publicado: (2021)

Ocular steroidome in human eyes and in eyes with complex central serous chorioretinopathy (CSCR)
por: Zola, Marta, et al.
Publicado: (2023)

Neurodegeneration and Neuroprotection in Glaucoma
por: Gauthier, Angela C., et al.
Publicado: (2016)

Neuroprotective therapies for glaucoma
por: Song, Wei, et al.
Publicado: (2015)

Neuroprotection in glaucoma-electrophysiology
por: Lešták, Ján, et al.
Publicado: (2020)

Olesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective Compound
por: Bordet, Thierry, et al.
Publicado: (2010)

Current perspective of neuroprotection and glaucoma
por: Tian, Kailin, et al.
Publicado: (2015)

Neuroprotective agents in the management of glaucoma
por: Nucci, C., et al.
Publicado: (2018)

Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease
por: Milanese, Chiara, et al.
Publicado: (2020)

Anesthetic Preconditioning as Endogenous Neuroprotection in Glaucoma
por: Chou, Tsung-Han, et al.
Publicado: (2018)

New perspectives of immunomodulation and neuroprotection in glaucoma
por: Skopiński, Piotr, et al.
Publicado: (2021)

The promise of neuroprotection by dietary restriction in glaucoma
por: Russo, Rossella, et al.
Publicado: (2021)

Niacinamide and Neuroprotection: The Glaucoma Holy Grail
por: Bhartiya, Shibal
Publicado: (2022)

A Coming of Age for Glaucoma Neuroprotection
por: Johnson, Thomas V.
Publicado: (2023)

Regulation of endocytic trafficking of transferrin receptor by optineurin and its impairment by a glaucoma-associated mutant
por: Nagabhushana, Ananthamurthy, et al.
Publicado: (2010)

Rapid endocytosis of the transferrin receptor in the absence of bound transferrin
Publicado: (1985)

Neuroprotection in Glaucoma: Old and New Promising Treatments
por: Rusciano, Dario, et al.
Publicado: (2017)

Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma
por: Adornetto, Annagrazia, et al.
Publicado: (2020)

Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
por: Tribble, James R., et al.
Publicado: (2021)

Neuroprotection in Glaucoma: Basic Aspects and Clinical Relevance
por: Kuo, Che-Yuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p9bcqlunm6leg6bsd05hor7gbt